VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Vaxjo
Vaxvec
Vaccine Mechanisms
Vaxism
Vaxmod
Vaccine Literature
Litesearch
Vaxpresso
Vaxmesh
Vaxlert
Vaccine Design
Vaxign
Community Efforts
Vaccine Ontology
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
VIOLIN Wiki
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Documents
FAQs
Links
Acknowledgements
Contact Us
UMMS Logo

Vaxlert: Peer-reviewed Vaccine Publications in Last Month

From Nov 01, 2008 To Nov 30, 2008 :

Bacillus anthracis (Anthrax)

  1. Liu TH, Oscherwitz J, Schnepp B, Jacobs J, Yu F, Cease KB, Johnson PR. Genetic Vaccines for Anthrax Based on Recombinant Adeno-associated Virus Vectors Molecular therapy : the journal of the American Society of Gene Therapy 2008 [PMID: 19002162]
  2. Niu MT, Ball R, Woo EJ, Burwen DR, Knippen M, Braun MM. Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007 Vaccine 2008 [PMID: 18992783]
  3. Nguyen ML, Crowe SR, Kurella S, Teryzan S, Cao B, Ballard JD, James JA, Farris AD. Sequential B Cell Epitopes of Bacillus anthracis Lethal Factor Bind Lethal toxin-neutralizing Antibodies Infection and immunity 2008 [PMID: 18981257]
  4. Kim SH, Park SA, Kim HK, Cho YJ, Kim KS, Kim YH, Chun JH, Lee NG. Enhancement of the immune responses of mice to Bacillus anthracis protective antigen by CIA07 combined with alum Archives of pharmacal research 31(11):1385-1392 2008 [PMID: 19023533]
  5. Nordström-Lerner L. [The anthrax researcher took his life--was he a bioterrorist?] Lakartidningen 105(37):2501-2503 2008 [PMID: 19006871]
  6. Mongoh MN, Dyer NW, Stoltenow CL, Khaitsa ML. Risk factors associated with anthrax outbreak in animals in North Dakota, 2005: a retrospective case-control study Public health reports (Washington, D.C. : 1974) 123(3):352-359 2008 [PMID: 19006977]

Brucella (Brucellosis)

  1. Bellido D, Craig PO, Mozgovoj MV, Gonzalez DD, Wigdorovitz A, Goldbaum FA, Dus Santos MJ. Brucella spp. lumazine synthase as a bovine rotavirus antigen delivery system Vaccine 27(1):136-145 2009 [PMID: 18973781]
  2. Grilló MJ, Marín CM, Barberán M, de Miguel MJ, Laroucau K, Jacques I, Blasco JM. Efficacy of bp26 and bp26/omp31 B. melitensis Rev.1 deletion mutants against Brucella ovis in rams Vaccine 2008 [PMID: 19007836]
  3. Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J. Immunization with recombinant Brucella spp. outer membrane proteins Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection Infection and immunity 2008 [PMID: 18981242]
  4. Robles CA, Nielsen K, Gall D, Willems P. Evaluation of three different antigens in an indirect enzyme-linked immunoassay for the detection of antibodies against Brucella abortus SRB51 in vaccinated heifers Veterinary immunology and immunopathology 2008 [PMID: 18980780]

Burkholderia mallei (Glanders)

  1. Bondi SK, Goldberg JB. Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei Expert review of vaccines 7(9):1357-1365 2008 [PMID: 18980539]

Burkholderia pseudomallei (Melioidosis)

  1. Bondi SK, Goldberg JB. Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei Expert review of vaccines 7(9):1357-1365 2008 [PMID: 18980539]

Clostridium perfringens

  1. Alam SI, Bansod S, Singh L. Immunization against Clostridium perfringens cells elicits protection against Clostridium tetani in mouse model: identification of cross-reactive proteins using proteomic methodologies BMC microbiology 8(1):194 2008 [PMID: 19000325]
  2. Song J, Qian M, Bai J, Zhao B. [Construction and immunogenicity of a genetic engineered strain expressing nontoxic ST1-LT(B)-alpha-beta fusion protein against diarrhea of piglet] Sheng wu gong cheng xue bao = Chinese journal of biotechnology 24(8):1340-1347 2008 [PMID: 18998533]

Cryptosporidium parvum

  1. Pangasa A, Jex AR, Campbell BE, Bott NJ, Whipp M, Hogg G, Stevens MA, Gasser RB. High resolution melting-curve (HRM) analysis for the diagnosis of cryptosporidiosis in humans Molecular and cellular probes 2008 [PMID: 19013516]

Ebola virus

  1. Strong JE, Wong G, Jones SE, Grolla A, Theriault S, Kobinger GP, Feldmann H. Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway Proceedings of the National Academy of Sciences of the United States of America 105(46):17982-17987 2008 [PMID: 18981410]
  2. Bukreyev A, Marzi A, Feldmann F, Zhang L, Yang L, Ward JM, Dorward DW, Pickles RJ, Murphy BR, Feldmann H, Collins PL. Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge Virology 2008 [PMID: 19010509]
  3. Sun Y, Carrion R Jr, Ye L, Wen Z, Ro YT, Brasky K, Ticer AE, Schwegler EE, Patterson JL, Compans RW, Yang C. Protection against lethal challenge by Ebola virus-like particles produced in insect cells Virology 2008 [PMID: 18986663]
  4. Towner JS, Sealy TK, Khristova ML, Albariño CG, Conlan S, Reeder SA, Quan PL, Lipkin WI, Downing R, Tappero JW, Okware S, Lutwama J, Bakamutumaho B, Kayiwa J, Comer JA, Rollin PE, Ksiazek TG, Nichol ST. Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda PLoS pathogens 4(11):e1000212 2008 [PMID: 19023410]

Escherichia coli

  1. Mu F, Niu D, Mu J, He B, Han W, Fan B, Huang S, Qiu Y, You B, Chen W. The expression and antigenicity of a truncated spike-nucleocapsid fusion protein of severe acute respiratory syndrome-associated coronavirus BMC microbiology 8(1):207 2008 [PMID: 19038059]
  2. Bouzari S, Dashti A, Jafari A, Oloomi M. Immune response against adhesins of enteroaggregative Escherichia coli immunized by three different vaccination strategies (DNA/DNA, Protein/Protein, and DNA/Protein) in mice Comparative immunology, microbiology and infectious diseases 2008 [PMID: 19022502]
  3. Cui HY, Wang YF, Shi XM, An TQ, Tong GZ, Lan DS, He L, Liu CJ, Wang M. Construction of an infectious Marek's disease virus bacterial artificial chromosome and characterization of protection induced in chickens Journal of virological methods 2008 [PMID: 19026690]
  4. Kosaki H, Wolt JD, Wang K, Coats JR. Subacute Effects of Maize-Expressed Vaccine Protein, Escherichia coli Heat-Labile Enterotoxin Subunit B (LTB), on the Springtail, Folsomia candida, and the Earthworm, Eisenia fetida Journal of agricultural and food chemistry 2008 [PMID: 19012409]
  5. Russo TA, Beanan JM, Olson R, Macdonald U, Cope JJ. Capsular polysaccharide and the O-specific antigen impede antibody binding: A potential obstacle for the successful development of an extraintestinal pathogenic Escherichia coli vaccine Vaccine 2008 [PMID: 19014988]
  6. Li P, Cao RB, Zheng QS, Liu JJ, Li Y, Wang EX, Li F, Chen PY. Enhancement of humoral and cellular immunity in mice against Japanese encephalitis virus using a DNA prime-protein boost vaccine strategy Veterinary journal (London, England : 1997) 2008 [PMID: 19008134]
  7. Schild S, Nelson EJ, Bishop AL, Camilli A. Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera Infection and immunity 2008 [PMID: 19001078]
  8. Coler RN, Dillon DC, Skeiky YA, Kahn M, Orme IM, Lobet Y, Reed SG, Alderson MR. Identification of Mycobacterium tuberculosis vaccine candidates using human CD4(+) T-cells expression cloning Vaccine 2008 [PMID: 19000730]
  9. Lodato PB, Kaper JB. Post-transcriptional processing of the LEE4 operon in Enterohemorrhagic Escherichia coli Molecular microbiology 2008 [PMID: 19019141]
  10. Weinke T, Liebold I, Burchard GD, Frühwein N, Grobusch MP, Hatz C, Kollaritsch H, Nothdurft HD, Reisinger E, Rieke B, Schönfeld Ch, Steffen R, Stich A. Prophylactic immunisation against traveller's diarrhoea caused by enterotoxin-forming strains of Escherichia coli and against cholera: Does it make sense and for whom? Travel medicine and infectious disease 6(6):362-367 2008 [PMID: 18984481]
  11. Wang Y, Shan C, Ming S, Liu Y, Du Y, Jiang G. Immunoadjuvant effects of bacterial genomic DNA and CpG oligodeoxynucleotides on avian influenza virus subtype H5N1 inactivated oil emulsion vaccine in chicken Research in veterinary science 2008 [PMID: 18977008]
  12. Du LF, Li ZJ, Tang XY, Huang JQ, Sun WB. Immunogenicity and immunoprotection of recombinant PEB1 in Campylobacter-jejuni-infected mice World journal of gastroenterology : WJG 14(40):6244-6248 2008 [PMID: 18985818]
  13. Dwars RM, Matthijs MG, Daemen AJ, van Eck JH, Vervelde L, Landman WJ. Progression of lesions in the respiratory tract of broilers after single infection with Escherichia coli compared to superinfection with E. coli after infection with infectious bronchitis virus Veterinary immunology and immunopathology 2008 [PMID: 19004507]
  14. Ravin NV, Kuprianov VV, Zamchuk LA, Kochetov AV, Dorokhov YL, Atabekov JG, Skryabin KG. Highly efficient expression of Escherichia coli heat-labile enterotoxin B subunit in plants using potato virus X-based vector Biochemistry. Biokhimiia 73(10):1108-1113 2008 [PMID: 18991556]
  15. Matthijs MG, Ariaans MP, Dwars RM, van Eck JH, Bouma A, Stegeman A, Vervelde L. Course of infection and immune responses in the respiratory tract of IBV infected broilers after superinfection with E. coli Veterinary immunology and immunopathology 2008 [PMID: 18976820]
  16. Song J, Qian M, Bai J, Zhao B. [Construction and immunogenicity of a genetic engineered strain expressing nontoxic ST1-LT(B)-alpha-beta fusion protein against diarrhea of piglet] Sheng wu gong cheng xue bao = Chinese journal of biotechnology 24(8):1340-1347 2008 [PMID: 18998533]

Francisella tularensis (Tularemia)

  1. Sebastian S, Pinkham JT, Lynch JG, Ross RA, Reinap B, Blalock LT, Conlan JW, Kasper DL. Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis Vaccine 2008 [PMID: 19022323]
  2. Qin A, Scott DW, Thompson JA, Mann BJ. Identification of an essential Francisella tularensis subsp. tularensis virulence factor Infection and immunity 2008 [PMID: 18981253]
  3. Bar-Haim E, Gat O, Markel G, Cohen H, Shafferman A, Velan B. Interrelationship between dendritic cell trafficking and Francisella tularensis dissemination following airway infection PLoS pathogens 4(11):e1000211 2008 [PMID: 19023422]
  4. Elkins KL, Colombini SM, Krieg AM, De Pascalis R. NK cells activated in vivo by bacterial DNA control the intracellular growth of Francisella tularensis LVS Microbes and infection / Institut Pasteur 2008 [PMID: 18992838]

Hantavirus

  1. Cao SC, Li JD, Lu P, Liu F, Wang Q, Liu QZ, Zhang QF, Li C, An Q, Liang MF, Li DX. [Hantavirus mucosal vaccine through different mucosal with heat-labile enterotoxin B subunit as adjuvants] Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 22(3):174-176 2008 [PMID: 19031694]

Human immunodeficiency virus (acquired immunodeficiency syndrome)

  1. Patterson S, Papagatsias T, Benlahrech A. Use of Adenovirus in Vaccines for HIV Handbook of experimental pharmacology (188):275-293 2009 [PMID: 19031031]
  2. Metadilogkul O, Jirathitikal V, Bourinbaiar AS. Serodeconversion of HIV antibody-positive AIDS patients following treatment with V-1 Immunitor Journal of biomedicine & biotechnology 2009:934579 2009 [PMID: 18989372]
  3. Montefiori DC. Measuring HIV Neutralization in a Luciferase Reporter Gene Assay Methods in molecular biology (Clifton, N.J.) 485:395-405 2009 [PMID: 19020839]
  4. Maecker HT. Multiparameter flow cytometry monitoring of T cell responses Methods in molecular biology (Clifton, N.J.) 485:375-391 2009 [PMID: 19020838]
  5. Shacklett BL, Critchfield JW, Lemongello D. Quantifying HIV-1-Specific CD8 (+) T-Cell Responses Using ELISPOT and Cytokine Flow Cytometry Methods in molecular biology (Clifton, N.J.) 485:359-374 2009 [PMID: 19020837]
  6. Joseph A, Sango K, Goldstein H. Novel Mouse Models for Understanding HIV-1 Pathogenesis Methods in molecular biology (Clifton, N.J.) 485:311-327 2009 [PMID: 19020834]
  7. Ott DE. Purification of HIV-1 Virions by Subtilisin Digestion or CD45 Immunoaffinity Depletion for Biochemical Studies Methods in molecular biology (Clifton, N.J.) 485:15-25 2009 [PMID: 19020815]
  8. Cruciani M, Mengoli C, Serpelloni G, Lanza A, Gomma M, Nardi S, Rimondo C, Bricolo F, Consolaro S, Trevisan M, Bosco O. Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients Vaccine 27(1):17-22 2009 [PMID: 18984022]
  9. Harries J, Moodley J, Barone MA, Mall S, Sinanovic E. Preparing for HPV vaccination in South Africa: Key challenges and opinions Vaccine 27(1):38-44 2009 [PMID: 18977271]
  10. Quirk EK, Mogg R, Brown DD, Lally MA, Mehrotra DV, DiNubile MJ, Robertson MN. HIV seroconversion without infection after receipt of adenovirus-vectored HIV type 1 vaccine Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 47(12):1593-1599 2008 [PMID: 18990058]
  11. Li Z, Gilbert P, Nan B. Weighted likelihood method for grouped survival data in case-cohort studies with application to HIV vaccine trials Biometrics 64(4):1247-1255 2008 [PMID: 19032178]
  12. Hesseling AC, Cotton MF, Fordham von Reyn C, Graham SM, Gie RP, Hussey GD. Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants: Submitted on behalf of the BCG Working Group, Child Lung Health Section, International Union Against Tuberculosis and Lung Disease, 38th Union World Conference on Lung Health, Cape Town, 8-12 November 2007 The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 12(12):1376-1379 2008 [PMID: 19017445]
  13. Sundling C, Schön K, Mörner A, Forsell MN, Wyatt RT, Thorstensson R, Karlsson Hedestam GB, Lycke NY. CTA1-DD adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunization The Journal of general virology 89(Pt 12):2954-2964 2008 [PMID: 19008380]
  14. Geldmacher C, Schuetz A, Ngwenyama N, Casazza JP, Sanga E, Saathoff E, Boehme C, Geis S, Maboko L, Singh M, Minja F, Meyerhans A, Koup RA, Hoelscher M. Early Depletion of Mycobacterium tuberculosis-Specific T Helper 1 Cell Responses after HIV-1 Infection The Journal of infectious diseases 198(11):1590-1598 2008 [PMID: 19000013]
  15. DeGruttola V, Little S, Schooley R. Controlling the HIV epidemic, without a vaccine! AIDS (London, England) 22(18):2554-2555 2008 [PMID: 19005285]
  16. Robb ML. Failure of the Merck HIV vaccine: an uncertain step forward Lancet 372(9653):1857-1858 2008 [PMID: 19012958]
  17. McElrath MJ, De Rosa SC, Moodie Z, Dubey S, Kierstead L, Janes H, Defawe OD, Carter DK, Hural J, Akondy R, Buchbinder SP, Robertson MN, Mehrotra DV, Self SG, Corey L, Shiver JW, Casimiro DR. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis Lancet 372(9653):1894-1905 2008 [PMID: 19012957]
  18. Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, Gilbert PB, Lama JR, Marmor M, Del Rio C, McElrath MJ, Casimiro DR, Gottesdiener KM, Chodakewitz JA, Corey L, Robertson MN. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial Lancet 372(9653):1881-1893 2008 [PMID: 19012954]
  19. Etcheverry MF, de Lazzari E, Fuchs JD, Meroño M, Sierra E, Romero JD, Evans JL, Mendez-Arancibia E, Jacques C, Rojas D, Segú M, Gatell JM, Joseph J. Pilot Study Assessing HIV Vaccine Trial Readiness Among Female Sex Workers, Injection and Non-injection Drug Users, and Men Who Have Sex with Men in Spain AIDS and behavior 2008 [PMID: 19037720]
  20. Whiteside TL, Piazza P, Reiter A, Stanson J, Connolly NC, Rinaldo CR Jr, Riddler SA. Production of DC-based vaccine containing inactivated autologous virus for therapy of patients with chronic HIV-1 infection Clinical and vaccine immunology : CVI 2008 [PMID: 19038780]
  21. Lin FC, Peng Y, Jones LA, Verardi PH, Yilma TD. Incorporation of CD40 Ligand into the Envelope of Pseudotyped Single-Cycle Simian Immunodeficiency Viruses Enhances Immunogenicity Journal of virology 2008 [PMID: 19036823]
  22. Wang YE, Li B, Carlson JM, Streeck H, Gladden AD, Goodman R, Schneidewind A, Power KA, Toth I, Frahm N, Alter G, Brander C, Carrington M, Walker BD, Altfeld M, Heckerman D, Allen TM. Protective HLA Class I Alleles Restricting Acute-Phase CD8+ T Cell Responses are Associated with Viral Escape Mutations Located in Highly Conserved Regions of HIV-1 Journal of virology 2008 [PMID: 19036810]
  23. Perreau M, Pantaleo G, Kremer EJ. Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells The Journal of experimental medicine 205(12):2717-2725 2008 [PMID: 18981239]
  24. Bandawe GP, Martin DP, Treurnicht F, Mlisana K, Abdool Karim SS, Williamson C, Caprisa 002 Acute Infection Study Team T. Conserved positive selection signals in HIV-1 gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection Virology journal 5(1):141 2008 [PMID: 19025632]
  25. Ptak RG, Fu W, Sanders-Beer BE, Dickerson JE, Pinney JW, Robertson DL, Rozanov MN, Katz KS, Maglott DR, Pruitt KD, Dieffenbach CW. Cataloguing the HIV Type 1 Human Protein Interaction Network AIDS research and human retroviruses 2008 [PMID: 19025396]
  26. Nikolaeva LG, Maystat TV, Pylypchuk VS, Volyanskii YL, Frolov VM, Kutsyna GA. Cytokine profiles of HIV patients with pulmonary tuberculosis resulting from adjunct immunotherapy with herbal phytoconcentrates Dzherelo and Anemin Cytokine 2008 [PMID: 19027322]
  27. Nyambi P, Burda S, Urbanski M, Heyndrickx L, Janssens W, Vanham G, Nadas A. Neutralization Patterns and Evolution of Sequential HIV Type 1 Envelope Sequences in HIV Type 1 Subtype B-Infected Drug-Naive Individuals AIDS research and human retroviruses 2008 [PMID: 19018670]
  28. Siddappa NB, Song R, Kramer VG, Chenine AL, Velu V, Ong H, Rasmussen RA, Grisson RD, Wood C, Zhang H, Kankasa C, Amara RR, Else JG, Novembre FJ, Montefiori DC, Ruprecht RM. Neutralization-Sensitive R5 SHIV-2873Nip Encoding env from a Infant with Recent HIV Clade C Infection Journal of virology 2008 [PMID: 19019970]
  29. Davis KL, Bibollet-Ruche F, Li H, Decker JM, Kutsch O, Morris L, Salomon A, Pinter A, Hoxie JA, Hahn BH, Kwong PD, Shaw GM. HIV-2/HIV-1 Envelope Chimeras Detect High Titers of Broadly Reactive HIV-1 V3-Specific Antibodies in Human Plasma Journal of virology 2008 [PMID: 19019969]
  30. Duda A, Turner L, Fox J, Robinson N, Dustan S, Kaye S, Fryer H, Carrington M, McClure M, McLean AR, Fidler S, Weber J, Phillips RE, Frater AJ. HLA-ASSOCIATED CLINICAL PROGRESSION CORRELATES WITH EPITOPE REVERSION RATES IN EARLY HIV INFECTION Journal of virology 2008 [PMID: 19019964]
  31. Bouzari S, Dashti A, Jafari A, Oloomi M. Immune response against adhesins of enteroaggregative Escherichia coli immunized by three different vaccination strategies (DNA/DNA, Protein/Protein, and DNA/Protein) in mice Comparative immunology, microbiology and infectious diseases 2008 [PMID: 19022502]
  32. Matoba N, Kajiura H, Cherni I, Doran JD, Bomsel M, Fujiyama K, Mor TS. Biochemical and immunological characterization of the plant-derived candidate human immunodeficiency virus type 1 mucosal vaccine CTB-MPR(649-684) Plant biotechnology journal 2008 [PMID: 19037902]
  33. Monath TP, Frey SE. Possible autoimmune reactions following smallpox vaccination: The biologic false positive test for syphilis Vaccine 2008 [PMID: 19022322]
  34. Huisman W, Martina BE, Rimmelzwaan GF, Gruters RA, Osterhaus AD. Vaccine-induced enhancement of viral infections Vaccine 2008 [PMID: 19022319]
  35. Gilbert PB, Sato A, Sun X, Mehrotra DV. Efficient and robust method for comparing the immunogenicity of candidate vaccines in randomized clinical trials Vaccine 2008 [PMID: 19022314]
  36. Mörner A, Douagi I, Forsell MN, Sundling C, Dosenovic P, O'dell S, Dey B, Kwong PD, Voss G, Thorstensson R, Mascola JR, Wyatt RT, Karlsson Hedestam GB. HIV-1 Env-trimer immunization of macaques and impact of priming with viral vector or stabilized core protein Journal of virology 2008 [PMID: 19004960]
  37. Carnero E, Li W, Borderia AV, Moltedo B, Moran T, García-Sastre A. Optimization of HIVGag expression by Newcastle disease virus vectors for the induction of potent immune responses Journal of virology 2008 [PMID: 19004953]
  38. Li Y, Svehla K, Louder MK, Wycuff D, Phogat S, Tang M, Migueles SA, Wu X, Phogat A, Shaw GM, Connors M, Hoxie J, Mascola JR, Wyatt R. Analysis of the Neutralization Specificities in Polyclonal Sera Derived from Human Immunodeficiency Virus Type-1 Infected Individuals Journal of virology 2008 [PMID: 19004942]
  39. Liu J, O'Brien KL, Lynch DM, Simmons NL, La Porte A, Riggs AM, Abbink P, Coffey RT, Grandpre LE, Seaman MS, Landucci G, Forthal DN, Montefiori DC, Carville A, Mansfield KG, Havenga MJ, Pau MG, Goudsmit J, Barouch DH. Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys Nature 2008 [PMID: 18997770]
  40. Lapelosa M, Gallicchio E, Arnold GF, Arnold E, Levy RM. In Silico Vaccine Design Based on Molecular Simulations of Rhinovirus Chimeras Presenting HIV-1 gp41 Epitopes Journal of molecular biology 2008 [PMID: 19026659]
  41. Mansoor N, Abel B, Scriba TJ, Hughes J, de Kock M, Tameris M, Mlenjeni S, Denation L, Little F, Gelderbloem S, Hawkridge A, Boom WH, Kaplan G, Hussey GD, Hanekom WA. Significantly skewed memory CD8(+) T cell subsets in HIV-1 infected infants during the first year of life Clinical immunology (Orlando, Fla.) 2008 [PMID: 18996749]
  42. Spearman P, Kalams S, Elizaga M, Metch B, Chiu YL, Allen M, Weinhold KJ, Ferrari G, Parker SD, McElrath MJ, Frey SE, Fuchs JD, Keefer MC, Lubeck MD, Egan M, Braun R, Eldridge JH, Haynes BF, Corey L. Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial Vaccine 2008 [PMID: 18996425]
  43. Andrade MC, Leite JP, Cabello PH. Frequency of the major histocompatibility complex Mamu-A*01 allele in a closed breeding colony of rhesus monkey (Macaca mulatta) from Brazil Journal of medical primatology 2008 [PMID: 19018945]
  44. Sather DN, Armann J, Ching LK, Mavrantoni A, Sellhorn G, Caldwell Z, Yu X, Wood B, Self S, Kalams S, Stamatatos L. Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during HIV-1 Infection Journal of virology 2008 [PMID: 18987148]
  45. Ko SY, Cheng C, Kong WP, Wang L, Kanekiyo M, Einfeld D, King CR, Gall JG, Nabel GJ. Enhanced induction of intestinal cellular immunity by oral priming with enteric adenovirus 41 vectors Journal of virology 2008 [PMID: 18987146]
  46. Mendiratta S, Vajpayee M, Malhotra U, Kaushik S, Dar L, Mojumdar K, Chauhan NK, Sreenivas V. Characterization of Gag and Nef-specific ELISpot-based CTL responses in HIV-1 infected Indian individuals Medical microbiology and immunology 2008 [PMID: 18985383]
  47. Cerini F, Landay A, Gichinga C, Lederman MM, Flyckt R, Starks D, Offord RE, Gal FL, Hartley O. Chemokine Analogues Show Suitable Stability for Development as Microbicides Journal of acquired immune deficiency syndromes (1999) 2008 [PMID: 18989226]
  48. Bråve A, Hallengärd D, Malm M, Blazevic V, Rollman E, Stanescu I, Krohn K. Combining DNA technologies and different modes of immunization for induction of humoral and cellular anti-HIV-1 immune responses Vaccine 2008 [PMID: 18992294]
  49. Sarafianos SG, Marchand B, Das K, Himmel D, Parniak MA, Hughes SH, Arnold E. Structure and Function of HIV-1 Reverse Transcriptase: Molecular Mechanisms of Polymerization and Inhibition Journal of molecular biology 2008 [PMID: 19022262]
  50. Torda AJ. Vaccination and screening of medical students: results of a student health initiative The Medical journal of Australia 189(9):484-486 2008 [PMID: 18976187]
  51. Ouyang D, Xu L, Dai Z, Shi H, Zhang G, Zheng Y, He X. Identification of major histocompatibility complex class I alleles in Chinese rhesus macaques Acta biochimica et biophysica Sinica 40(11):919-927 2008 [PMID: 18989572]
  52. Silbermann B, Tod M, Desaint C, Pialoux G, Petitprez K, Slama L, Poncelet H, Moreau C, Mazarin V, Heshmati F, Salmon-Ceron D, Guillet JG, Launay O. Short communication: Long-term persistence of vaccine-induced HIV seropositivity among healthy volunteers AIDS research and human retroviruses 24(11):1445-1448 2008 [PMID: 19000023]
  53. Speelmon EC, Livingston-Rosanoff D, Desbien AL, Lee J, Wick WD, Hladik F, McElrath MJ. Impaired viral entry cannot explain reduced CD4+ T cell susceptibility to HIV type 1 in certain highly exposed individuals AIDS research and human retroviruses 24(11):1415-1427 2008 [PMID: 19000021]
  54. Chung A, Rollman E, Johansson S, Kent SJ, Stratov I. The utility of ADCC responses in HIV infection Current HIV research 6(6):515-519 2008 [PMID: 18991616]
  55. Baroncelli S, Negri DR, Michelini Z, Cara A. Macaca mulatta, fascicularis and nemestrina in AIDS vaccine development Expert review of vaccines 7(9):1419-1434 2008 [PMID: 18980543]
  56. McBurney SP, Ross TM. Viral sequence diversity: challenges for AIDS vaccine designs Expert review of vaccines 7(9):1405-1417 2008 [PMID: 18980542]
  57. Demirjian A, Levy O. Novel vaccines: bridging research, development and production Expert review of vaccines 7(9):1321-1324 2008 [PMID: 18980535]
  58. Cutler B, Justman J. Vaginal microbicides and the prevention of HIV transmission The Lancet infectious diseases 8(11):685-697 2008 [PMID: 18992405]
  59. Carlson JM, Brumme ZL, Rousseau CM, Brumme CJ, Matthews P, Kadie C, Mullins JI, Walker BD, Harrigan PR, Goulder PJ, Heckerman D. Phylogenetic dependency networks: inferring patterns of CTL escape and codon covariation in HIV-1 Gag PLoS computational biology 4(11):e1000225 2008 [PMID: 19023406]
  60. Zhu P, Winkler H, Chertova E, Taylor KA, Roux KH. Cryoelectron tomography of HIV-1 envelope spikes: further evidence for tripod-like legs PLoS pathogens 4(11):e1000203 2008 [PMID: 19008954]
  61. Kubba T. Human papillomavirus vaccination in the United Kingdom: what about boys? Reproductive health matters 16(32):97-9103 2008 [PMID: 19027627]
  62. Endsley JJ, Waters WR, Palmer MV, Nonnecke BJ, Thacker TC, Jacobs WR Jr, Larsen MH, Hogg A, Shell E, McAlauy M, Scherer CF, Coffey T, Howard CJ, Villareal-Ramos B, Estes DM. The calf model of immunity for development of a vaccine against tuberculosis Veterinary immunology and immunopathology 2008 [PMID: 19027175]
  63. Haubrich R, Soriano V, Lafeuillade A. Statements from the 15th International Symposium on HIV and Emerging Infectious Diseases (ISHEID), Toulon, France, May 28-30, 2008 HIV clinical trials 9(5):348-365 2008 [PMID: 18977724]
  64. Ariga H, Harada N. [Evolution of IGRA researches] Kekkaku : [Tuberculosis] 83(9):641-652 2008 [PMID: 18979999]
  65. Almonte M, Albero G, Molano M, Carcamo C, García PJ, Pérez G. Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean Vaccine 26 Suppl 11:L16-36 2008 [PMID: 18945400]
  66. Jablonowski H. [HIV vaccination] MMW Fortschritte der Medizin 150 Spec No 1:68-69 2008 [PMID: 19031568]
  67. Johnson RW, Wasner G, Saddier P, Baron R. Herpes zoster and postherpetic neuralgia : optimizing management in the elderly patient Drugs & aging 25(12):991-991006 2008 [PMID: 19021299]
  68. Davison SM, Kelly DA. Management strategies for hepatitis C virus infection in children Paediatric drugs 10(6):357-365 2008 [PMID: 18998746]
  69. Kulkarni H, Marconi VC, Agan BK, McArthur C, Crawford G, Clark RA, Dolan MJ, Ahuja SK. Role of CCL3L1-CCR5 genotypes in the epidemic spread of HIV-1 and evaluation of vaccine efficacy PLoS ONE 3(11):e3671 2008 [PMID: 18989363]
  70. Catano G, Kulkarni H, He W, Marconi VC, Agan BK, Landrum M, Anderson S, Delmar J, Telles V, Song L, Castiblanco J, Clark RA, Dolan MJ, Ahuja SK. HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles PLoS ONE 3(11):e3636 2008 [PMID: 18982067]
  71. Saïdi H, Melki MT, Gougeon ML. HMGB1-dependent triggering of HIV-1 replication and persistence in dendritic cells as a consequence of NK-DC cross-talk PLoS ONE 3(10):e3601 2008 [PMID: 18974890]

Mycobacterium tuberculosis (tuberculosis)

  1. Badell E, Nicolle F, Clark S, Majlessi L, Boudou F, Martino A, Castello-Branco L, Leclerc C, Lewis DJ, Marsh PD, Gicquel B, Winter N. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells Vaccine 27(1):28-37 2009 [PMID: 18977269]
  2. Marra F, Marra CA, Sadatsafavi M, Morán-Mendoza O, Cook V, Elwood RK, Morshed M, Brunham RC, Fitzgerald JM. Cost-effectiveness of a new interferon-based blood assay, QuantiFERON(R)-TB Gold, in screening tuberculosis contacts The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 12(12):1414-1424 2008 [PMID: 19017451]
  3. Teixeira EG, Kritski A, Ruffino-Netto A, Steffen R, Lapa E Silva JR, Belo M, Luiz RR, Menzies D, Trajman A. Two-step tuberculin skin test and booster phenomenon prevalence among Brazilian medical students The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 12(12):1407-1413 2008 [PMID: 19017450]
  4. Chan PC, Chang LY, Wu YC, Lu CY, Kuo HS, Lee CY, Huang LM, Chen CJ. Age-specific cut-offs for the tuberculin skin test to detect latent tuberculosis in BCG-vaccinated children The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 12(12):1401-1406 2008 [PMID: 19017449]
  5. Hesseling AC, Cotton MF, Fordham von Reyn C, Graham SM, Gie RP, Hussey GD. Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants: Submitted on behalf of the BCG Working Group, Child Lung Health Section, International Union Against Tuberculosis and Lung Disease, 38th Union World Conference on Lung Health, Cape Town, 8-12 November 2007 The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 12(12):1376-1379 2008 [PMID: 19017445]
  6. Bertholet S, Ireton GC, Kahn M, Guderian J, Mohamath R, Stride N, Laughlin EM, Baldwin SL, Vedvick TS, Coler RN, Reed SG. Identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosis Journal of immunology (Baltimore, Md. : 1950) 181(11):7948-7957 2008 [PMID: 19017986]
  7. Geldmacher C, Schuetz A, Ngwenyama N, Casazza JP, Sanga E, Saathoff E, Boehme C, Geis S, Maboko L, Singh M, Minja F, Meyerhans A, Koup RA, Hoelscher M. Early Depletion of Mycobacterium tuberculosis-Specific T Helper 1 Cell Responses after HIV-1 Infection The Journal of infectious diseases 198(11):1590-1598 2008 [PMID: 19000013]
  8. Kim SY, Lee BS, Shin SJ, Kim HJ, Park JK. Differentially expressed genes in Mycobacterium tuberculosis H37Rv under mild acidic and hypoxic conditions Journal of medical microbiology 57(Pt 12):1473-1480 2008 [PMID: 19018016]
  9. Lim J, Derrick SC, Kolibab K, Yang AL, Porcelli S, Jacobs WR, Morris SL. Post-infection characterization of early pulmonary cytokine and chemokine responses by PCR array in mice immunized with three different vaccines against Mycobacterium tuberculosis Clinical and vaccine immunology : CVI 2008 [PMID: 19038785]
  10. Zárate-Bladés CR, Bonato VL, da Silveira EL, E Paula MO, Junta CM, Sandrin-Garcia P, Fachin AL, Mello SS, Cardoso RS, de Sá Galetti FC, Coelho-Castelo AA, Ramos SG, Donadi EA, Sakamoto-Hojo ET, da Silva Passos GA, Silva CL. Comprehensive gene expression profiling in lungs of mice infected with Mycobacterium tuberculosis following DNAhsp65 immunotherapy The journal of gene medicine 2008 [PMID: 19035575]
  11. Rhodes A, Aw TC, Allen C, Ridout M. Immunisation status of dental practice staff in Kent British dental journal 205(10):E20; discussion 562-563 2008 [PMID: 19008925]
  12. Sugawara I, Sun L, Mizuno S, Taniyama T. Protective efficacy of recombinant BCG Tokyo (Ag85A) in rhesus monkeys (Macaca mulatta) infected intratracheally with H37Rv Mycobacterium tuberculosis Tuberculosis (Edinburgh, Scotland) 2008 [PMID: 19028143]
  13. Ribeiro AM, Bocca AL, Amaral AC, Faccioli LH, Galetti FC, Zárate-Bladés CR, Figueiredo F, Silva CL, Felipe MS. DNAhsp65 vaccination induces protection in mice against Paracoccidioides brasiliensis infection Vaccine 2008 [PMID: 19028537]
  14. Nikolaeva LG, Maystat TV, Pylypchuk VS, Volyanskii YL, Frolov VM, Kutsyna GA. Cytokine profiles of HIV patients with pulmonary tuberculosis resulting from adjunct immunotherapy with herbal phytoconcentrates Dzherelo and Anemin Cytokine 2008 [PMID: 19027322]
  15. Lankes HA, Fought AJ, Evens AM, Weisenburger DD, Chiu BC. Vaccination history and risk of non-hodgkin lymphoma: a population-based, case-control study Cancer causes & control : CCC 2008 [PMID: 19011978]
  16. Hawkridge A, Hatherill M, Little F, Goetz MA, Barker L, Mahomed H, Sadoff J, Hanekom W, Geiter L, Hussey G. Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial BMJ (Clinical research ed.) 337:a2052 2008 [PMID: 19008268]
  17. Lesellier S, Corner L, Costello E, Lyashchenko K, Greenwald R, Esfandiari J, Singh M, Hewinson RG, Chambers M, Gormley E. Immunological responses and protective immunity in BCG vaccinated badgers following endobronchial infection with Mycobacterium bovis Vaccine 2008 [PMID: 19010372]
  18. Horwitz MA, Harth G, Dillon BJ, Masleša-Galić S. Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosis Vaccine 2008 [PMID: 19007841]
  19. Coler RN, Dillon DC, Skeiky YA, Kahn M, Orme IM, Lobet Y, Reed SG, Alderson MR. Identification of Mycobacterium tuberculosis vaccine candidates using human CD4(+) T-cells expression cloning Vaccine 2008 [PMID: 19000730]
  20. Mansoor N, Abel B, Scriba TJ, Hughes J, de Kock M, Tameris M, Mlenjeni S, Denation L, Little F, Gelderbloem S, Hawkridge A, Boom WH, Kaplan G, Hussey GD, Hanekom WA. Significantly skewed memory CD8(+) T cell subsets in HIV-1 infected infants during the first year of life Clinical immunology (Orlando, Fla.) 2008 [PMID: 18996749]
  21. Jeevan A, Bonilla DL, McMurray DN. Expression of interferon-gamma and tumour necrosis factor-alpha messenger RNA does not correlate with protection in guinea pigs challenged with virulent Mycobacterium tuberculosis by the respiratory route Immunology 2008 [PMID: 19016908]
  22. Hogg AE, Worth A, Beverley P, Howard CJ, Villarreal-Ramos B. The antigen-specific memory CD8(+) T-cell response induced by BCG in cattle resides in the CD8(+)gamma/deltaTCR(-)CD45RO(+) T-cell population Vaccine 2008 [PMID: 18996428]
  23. Ferrer NL, Gómez AB, Soto CY, Neyrolles O, Gicquel B, Portillo FG, Martín C. Intracellular replication of attenuated Mycobacterium tuberculosis phoP mutant in the absence of host cell cytotoxicity Microbes and infection / Institut Pasteur 2008 [PMID: 19028596]
  24. Gupta A, Mol N, Mani J, Upadhyay P, Katoch VM, Natrajan M, Gupta UD, Bhaskar S. Immunogenicity and protective efficacy of M.w against M.tuberculosis in mice immunized with live M.w by aerosol or parenteral route and compared with killed M.w Infection and immunity 2008 [PMID: 18981249]
  25. Torda AJ. Vaccination and screening of medical students: results of a student health initiative The Medical journal of Australia 189(9):484-486 2008 [PMID: 18976187]
  26. Giri PK, Khuller GK. Is intranasal vaccination a feasible solution for tuberculosis? Expert review of vaccines 7(9):1341-1356 2008 [PMID: 18980538]
  27. Mokrousov I. Corynebacterium diphtheriae: Genome diversity, population structure and genotyping perspectives Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2008 [PMID: 19007916]
  28. Endsley JJ, Waters WR, Palmer MV, Nonnecke BJ, Thacker TC, Jacobs WR Jr, Larsen MH, Hogg A, Shell E, McAlauy M, Scherer CF, Coffey T, Howard CJ, Villareal-Ramos B, Estes DM. The calf model of immunity for development of a vaccine against tuberculosis Veterinary immunology and immunopathology 2008 [PMID: 19027175]
  29. Barbey C, Budin-Verneuil A, Cauchard S, Hartke A, Laugier C, Pichereau V, Petry S. Proteomic analysis and immunogenicity of secreted proteins from Rhodococcus equi ATCC 33701 Veterinary microbiology 2008 [PMID: 19019579]
  30. Okada M. [The development of novel vaccines against tuberculosis] Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology 31(5):356-368 2008 [PMID: 18974619]
  31. Lesellier S, Corner L, Costello E, Sleeman P, Lyashchenko KP, Greenwald R, Esfandiari J, Glyn Hewinson R, Chambers M, Gormley E. Immunological responses following experimental endobronchial infection of badgers (Meles meles) with different doses of Mycobacterium bovis Veterinary immunology and immunopathology 2008 [PMID: 18986710]
  32. Ariga H, Harada N. [Evolution of IGRA researches] Kekkaku : [Tuberculosis] 83(9):641-652 2008 [PMID: 18979999]
  33. Kobayashi K, Sugawara I. [Research and development of vaccines against tuberculosis] Kekkaku : [Tuberculosis] 83(9):635-640 2008 [PMID: 18979998]
  34. Guiard J, Collmann A, Gilleron M, Mori L, De Libero G, Prandi J, Puzo G. Synthesis of diacylated trehalose sulfates: candidates for a tuberculosis vaccine Angewandte Chemie (International ed. in English) 47(50):9734-9738 2008 [PMID: 18980166]
  35. Magalhaes I, Sizemore DR, Ahmed RK, Mueller S, Wehlin L, Scanga C, Weichold F, Schirru G, Pau MG, Goudsmit J, Kühlmann-Berenzon S, Spångberg M, Andersson J, Gaines H, Thorstensson R, Skeiky YA, Sadoff J, Maeurer M. rBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector PLoS ONE 3(11):e3790 2008 [PMID: 19023426]
  36. Kamath AT, Rochat AF, Valenti MP, Agger EM, Lingnau K, Andersen P, Lambert PH, Siegrist CA. Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvant PLoS ONE 3(11):e3683 2008 [PMID: 18997860]
  37. Tundup S, Pathak N, Ramanadham M, Mukhopadhyay S, Murthy KJ, Ehtesham NZ, Hasnain SE. The co-operonic PE25/PPE41 protein complex of Mycobacterium tuberculosis elicits increased humoral and cell mediated immune response PLoS ONE 3(10):e3586 2008 [PMID: 18974870]
  38. Kaufmann SH. Rational design of novel antibacterial vaccines with an emphasis on tuberculosis Scandinavian journal of infectious diseases 40(8):595-600 2008 [PMID: 18979596]

Plasmodium falciparum (Malaria)

  1. Iriemenam NC, Khirelsied AH, Nasr A, Elghazali G, Giha HA, A-Elgadir TM, Agab-Aldour AA, Montgomery SM, Anders RF, Theisen M, Troye-Blomberg M, Elbashir MI, Berzins K. Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan Vaccine 27(1):62-71 2009 [PMID: 18977268]
  2. Vanderberg JP. Reflections on early malaria vaccine studies, the first successful human malaria vaccination, and beyond Vaccine 27(1):2-9 2009 [PMID: 18973784]
  3. Saravia C, Martinez P, Granados DS, Lopez C, Reyes C, Patarroyo MA. Identification and evaluation of universal epitopes in Plasmodium vivax Duffy binding protein Biochemical and biophysical research communications 377(4):1279-1283 2008 [PMID: 19000655]
  4. Angel DI, Mongui A, Ardila J, Vanegas M, Patarroyo MA. The Plasmodium vivax Pv41 surface protein: Identification and characterization Biochemical and biophysical research communications 377(4):1113-1117 2008 [PMID: 18983983]
  5. Logan GJ, Wang L, Zheng M, Ginn SL, Coppel RL, Alexander IE. Antigen-specific humoral tolerance or immune augmentation induced by intramuscular delivery of adeno-associated viruses encoding CTLA4-Ig-antigen fusion molecules Gene therapy 2008 [PMID: 19037242]
  6. Reed ZH, Kieny MP, Engers H, Friede M, Chang S, Longacre S, Malhotra P, Pan W, Long C. Comparison of immunogenicity of five MSP1-based malaria vaccine candidate antigens in rabbits Vaccine 2008 [PMID: 19038302]
  7. Reilly LJ, Magkrioti C, Cavanagh DR, Mduluza T, Mutapi F. Effect of treating Schistosoma haematobium infection on Plasmodium falciparum-specific antibody responses BMC infectious diseases 8(1):158 2008 [PMID: 19014683]
  8. Wipasa J, Xu H, Liu X, Hirunpetcharat C, Stowers A, Good MF. Original antigenic sin and malaria subunit vaccines: the effect of Plasmodium yoelii exposure on vaccination with the 19 kDa carboxylterminus of the merozoite surface protein 1 (MSP119) and vice versa - implications for an application of human malaria vaccine Infection and immunity 2008 [PMID: 19015251]
  9. Buxbaum LU. A detrimental role for IgG and FcgammaR in Leishmania mexicana infection Immunologic research 2008 [PMID: 19002608]
  10. Bongfen SE, Ntsama PM, Offner S, Smith T, Felger I, Tanner M, Alonso P, Nebie I, Romero JF, Silvie O, Torgler R, Corradin G. The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity Vaccine 2008 [PMID: 18984024]
  11. Achur RN, Kakizaki I, Goel S, Kojima K, Madhunapantula SV, Goyal A, Ohta M, Kumar S, Takagaki K, Gowda DC. Structural Interactions in Chondroitin 4-Sulfate Mediated Adherence of Plasmodium falciparum Infected Erythrocytes in Human Placenta during Pregnancy-Associated Malaria Biochemistry 2008 [PMID: 18975976]
  12. Demirjian A, Levy O. Novel vaccines: bridging research, development and production Expert review of vaccines 7(9):1321-1324 2008 [PMID: 18980535]
  13. Maltezou HC. Visceral leishmaniasis: advances in treatment Recent patents on anti-infective drug discovery 3(3):192-198 2008 [PMID: 18991801]
  14. Silva-Flannery LM, Cabrera-Mora M, Jiang J, Moreno A. Recombinant peptide replicates immunogenicity of synthetic linear peptide chimera for use as pre-erythrocytic stage malaria vaccine Microbes and infection / Institut Pasteur 2008 [PMID: 19015042]
  15. Baum J, Chen L, Healer J, Lopaticki S, Boyle M, Triglia T, Ehlgen F, Ralph SA, Beeson JG, Cowman AF. Reticulocyte-binding protein homologue 5 - An essential adhesin involved in invasion of human erythrocytes by Plasmodium falciparum International journal for parasitology 2008 [PMID: 19000690]
  16. Hind CA, Bond CM, Lee AJ, van Teijlingen ER. Needs assessment study for community pharmacy travel medicine services Journal of travel medicine : official publication of the International Society of Travel Medicine and the Asia Pacific Travel Health Association 15(5):328-334 2008 [PMID: 19006506]
  17. Sharma B. Structure and mechanism of a transmission blocking vaccine candidate protein Pfs25 from In silico biology 8(3-4):193-206 2008 [PMID: 19032156]

Salmonella

  1. Sundström P, Lundin SB, Nilsson LA, Quiding-Järbrink M. Human IgA-secreting cells induced by intestinal, but not systemic, immunization respond to CCL25 (TECK) and CCL28 (MEC) European journal of immunology 38(12):3327-3338 2008 [PMID: 19003934]
  2. Preisler A, Heisig P. The role of intra- and extragenic compensatory mutations in the suppression of fluoroquinolone resistance in a Salmonella Typhimurium gyrA mutant (D87G) The Journal of antimicrobial chemotherapy 2008 [PMID: 19033246]
  3. Saxena M, Coloe PJ, Smooker PM. Humoral and T cell responses to a vectored antigen delivered by a Salmonella enterica vaccine: influence of promoter choice, gene copy number and opsonizing antibodies induced by prior immunity Clinical and vaccine immunology : CVI 2008 [PMID: 19005022]
  4. Boyen F, Pasmans F, Van Immerseel F, Donné E, Morgan E, Ducatelle R, Haesebrouck F. Porcine in vitro and in vivo models to assess the virulence of Salmonella enterica serovar Typhimurium for pigs Laboratory animals 2008 [PMID: 18987064]
  5. Hauer AD, Habets KL, van Wanrooij EJ, de Vos P, Krueger J, Reisfeld RA, van Berkel TJ, Kuiper J. Vaccination against TIE2 reduces atherosclerosis Atherosclerosis 2008 [PMID: 19022447]
  6. Pandit A, Arjyal A, Paudyal B, Campbell JC, Day JN, Farrar JJ, Basnyat B. A patient with paratyphoid A fever: an emerging problem in Asia and not always a benign disease Journal of travel medicine : official publication of the International Society of Travel Medicine and the Asia Pacific Travel Health Association 15(5):364-365 2008 [PMID: 19006513]
  7. Fangtham M, Wilde H. Emergence of Salmonella paratyphi A as a major cause of enteric fever: need for early detection, preventive measures, and effective vaccines Journal of travel medicine : official publication of the International Society of Travel Medicine and the Asia Pacific Travel Health Association 15(5):344-350 2008 [PMID: 19006508]

Shigella

  1. Simon J, Wahid R, Maciel M Jr, Picking WL, Kotloff KL, Levine MM, Sztein MB. Antigen-specific B memory cell responses to lipopolysaccharide (LPS) and invasion plasmid antigen (Ipa) B elicited in volunteers vaccinated with live-attenuated Shigella flexneri 2a vaccine candidates Vaccine 2008 [PMID: 19022324]
  2. Cyr SL, Angers I, Guillot L, Stoica-Popescu I, Lussier M, Qureshi S, Burt DS, Ward BJ. TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model Vaccine 2008 [PMID: 19013492]

Variola major (Smallpox)

  1. Agrawal S, Gupta S, Agrawal A. Vaccinia virus proteins activate human dendritic cells to induce T cell responses in vitro Vaccine 27(1):88-92 2009 [PMID: 18977270]
  2. Taub DD, Ershler WB, Janowski M, Artz A, Key ML, McKelvey J, Muller D, Moss B, Ferrucci L, Duffey PL, Longo DL. Immunity from smallpox vaccine persists for decades: a longitudinal study The American journal of medicine 121(12):1058-1064 2008 [PMID: 19028201]
  3. Huynh W, Cordato DJ, Kehdi E, Masters LT, Dedousis C. Post-vaccination encephalomyelitis: Literature review and illustrative case Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 15(12):1315-1322 2008 [PMID: 18976924]
  4. Midgley CM, Putz MM, Weber JN, Smith GL. Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax The Journal of general virology 89(Pt 12):2992-2997 2008 [PMID: 19008384]
  5. Melekhin VV, Karem KL, Damon IK, Bloch KC. Encephalitis after Secondary Smallpox Vaccination Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008 [PMID: 19025490]
  6. Ryan JE, Dhiman N, Ovsyannikova IG, Vierkant RA, Pankratz VS, Poland GA. Response surface methodology to determine optimal cytokine responses in human peripheral blood mononuclear cells after smallpox vaccination Journal of immunological methods 2008 [PMID: 19038260]
  7. Lederman E, Miramontes R, Openshaw J, Olson VA, Karem KL, Marcinak J, Panares R, Staggs W, Allen D, Weber SG, Vora S, Gerber SI, Hughes CM, Regnery R, Collins L, Diaz PS, Reynolds MG, Damon I. Eczema vaccinatum resulting from the transmission of vaccinia virus from a smallpox vaccinee: An investigation of potential fomites in the home environment Vaccine 2008 [PMID: 19027813]
  8. Monath TP, Frey SE. Possible autoimmune reactions following smallpox vaccination: The biologic false positive test for syphilis Vaccine 2008 [PMID: 19022322]
  9. Lankes HA, Fought AJ, Evens AM, Weisenburger DD, Chiu BC. Vaccination history and risk of non-hodgkin lymphoma: a population-based, case-control study Cancer causes & control : CCC 2008 [PMID: 19011978]
  10. Paran N, Suezer Y, Lustig S, Israely T, Schwantes A, Melamed S, Katz L, Preuß T, Hanschmann KM, Kalinke U, Erez N, Levin R, Velan B, Löwer J, Shafferman A, Sutter G. Postexposure Immunization with Modified Vaccinia Virus Ankara or Conventional Lister Vaccine Provides Solid Protection in a Murine Model of Human Smallpox The Journal of infectious diseases 2008 [PMID: 19012492]
  11. Anis E, Leventhal A, Slater PE, Shinar E, Yahalom V, Smetana Z, Zach R, Reznikovich S, Mendelson E, Danon Y, Lev B. Smallpox revaccination of 21000 first responders in Israel: lessons learned International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2008 [PMID: 19010077]
  12. Wei H, Huang D, Fortman J, Wang R, Shao L, Chen ZW. Cidofovir + Dryvax co-administration reduced Dryvax vaccination side effect but interfered with vaccine-elicited immune responses and anti-monkeypox immunity Journal of virology 2008 [PMID: 19004937]
  13. Demirjian A, Levy O. Novel vaccines: bridging research, development and production Expert review of vaccines 7(9):1321-1324 2008 [PMID: 18980535]
  14. . Society for Assisted Reproductive Technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus) Fertility and sterility 90(5 Suppl):S272-273 2008 [PMID: 19007644]
  15. Schultz DA, Sagartz JE, Huso DL, Buller RM. Experimental infection of an African dormouse (Graphiurus kelleni) with monkeypox virus Virology 2008 [PMID: 18977501]
  16. Ryan CP. Zoonoses likely to be used in bioterrorism Public health reports (Washington, D.C. : 1974) 123(3):276-281 2008 [PMID: 19006970]
  17. Smee DF. Progress in the discovery of compounds inhibiting orthopoxviruses in animal models Antiviral chemistry & chemotherapy 19(3):115-124 2008 [PMID: 19024628]

Venezuelan equine encephalitis virus

  1. Atkins GJ, Fleeton MN, Sheahan BJ. Therapeutic and prophylactic applications of alphavirus vectors Expert reviews in molecular medicine 10:e33 2008 [PMID: 19000329]

Vibrio cholerae

  1. Schild S, Nelson EJ, Bishop AL, Camilli A. Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera Infection and immunity 2008 [PMID: 19001078]
  2. Pérez JL, Acevedo R, Callicó A, Fernández Y, Cedré B, Año G, González L, Falero G, Talavera A, Pérez O, García L. A proteoliposome based formulation administered by the nasal route produces vibriocidal antibodies against El Tor Ogawa Vibrio cholerae O1 in BALB/c mice Vaccine 2008 [PMID: 18996426]

Yersinia pestis (Plague)

  1. Mizel SB, Graff AH, Sriranganathan N, Ervin S, Lees CJ, Lively MO, Hantgan RR, Thomas MJ, Wood J, Bell B. A Fusion Protein, Flagellin/F1/V, is an Effective Plague Vaccine in Mice and Two Species of Nonhuman Primates Clinical and vaccine immunology : CVI 2008 [PMID: 18987167]
  2. . [Preparation of fractions and characteristic of neutrophilokines complex induced by Yersinia pestis EV] Zhurnal mikrobiologii, epidemiologii, i immunobiologii (5):65-69 2008 [PMID: 19006834]

** Click HERE to see the latest publications in this month.